Is BAX Worth Buying in 2026?

Baxter International Inc.

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-06-07

Here’s whether Baxter International Inc. (BAX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.27% over 10 days); 3-month momentum positive (+8.2%). Concerns: trading below the 200-day MA (long-term downtrend); RSI 74 — overbought, elevated pullback risk; weak 1-year return of -35.7%. Currently 39.5% off its 52-week high. Score: -1/7.

Ready to act on this? 📈 Trade on Webull

BAX is trading below its 200-day MA ($19.87) — a key warning sign the longer-term trend is under pressure. With an RSI of 74.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -35.7% compares to +24.4% for SPY (trailed the market by 60.1%). The current 39.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $6,428 today
vs. S&P 500 (SPY) — same period trailed market by 60.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($19.87)
Above 50-day MA ($17.83)
!RSI(14) neutral zone (30–70) — currently 74.1
Positive return (-35.7%)
!Within 10% of period high (−39.5%)
Period Range $19.38
$15.73 $32.04
RSI (14) 74.1
0 · OversoldOverbought · 100

Key Metrics

Price$19.38
Period Return-35.7%
Period High$32.04
Period Low$15.73
Drawdown−39.5%
MA-50$17.83
MA-200$19.87
RSI (14)74.1
Avg Volume (30d)7.7M
vs. SPYtrailed by 60.1%
Return Rank#985 of 1245

Trade BAX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers